RS50527B - Derivati indanil-piperazina, proces njihove izrade i farmaceutske smeše koje ih sadrže - Google Patents

Derivati indanil-piperazina, proces njihove izrade i farmaceutske smeše koje ih sadrže

Info

Publication number: RS50527B
Authority: RS; Serbia
Prior art keywords: branched; linear; optionally substituted; halogen; group
Prior art date: 2005-03-30

Application number

RSP-2007/0478A

Other languages

English (en)

Inventor

Bernard Portevin

Guillaume De Nanteuil

Philippe Gloanec

Mark Millan

Jean-Claude Ortuno

Clotilde Mannoury La Cour

Alain Gobert

Original Assignee

Les Laboratoires Servier

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-30

Filing date

2006-03-29

Publication date

2010-05-07

2006-03-29 Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier

2010-05-07 Publication of RS50527B publication Critical patent/RS50527B/sr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

RSP-2007/0478A 2005-03-30 2006-03-29 Derivati indanil-piperazina, proces njihove izrade i farmaceutske smeše koje ih sadrže RS50527B (sr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0503071A FR2883876B1 (fr)	2005-03-30	2005-03-30	Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number	Publication Date
RS50527B true RS50527B (sr)	2010-05-07

Family

ID=35079249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
RSP-2007/0478A RS50527B (sr)	2005-03-30	2006-03-29	Derivati indanil-piperazina, proces njihove izrade i farmaceutske smeše koje ih sadrže

Country Status (37)

Country	Link
US (1)	US7442692B2 (sr)
EP (1)	EP1707564B1 (sr)
JP (1)	JP4503549B2 (sr)
KR (1)	KR100766664B1 (sr)
CN (1)	CN100467458C (sr)
AP (1)	AP2007004169A0 (sr)
AR (1)	AR054747A1 (sr)
AT (1)	ATE372992T1 (sr)
AU (1)	AU2006201326A1 (sr)
BR (1)	BRPI0602132A (sr)
CA (1)	CA2541066C (sr)
CR (1)	CR9391A (sr)
CY (1)	CY1107028T1 (sr)
DE (1)	DE602006000102T2 (sr)
DK (1)	DK1707564T3 (sr)
EA (1)	EA010051B1 (sr)
ES (1)	ES2293630T3 (sr)
FR (1)	FR2883876B1 (sr)
GE (1)	GEP20084544B (sr)
GT (1)	GT200700084A (sr)
HK (1)	HK1096386A1 (sr)
HR (1)	HRP20070498T3 (sr)
IL (1)	IL186062A (sr)
MA (1)	MA28211A1 (sr)
MX (1)	MXPA06003552A (sr)
MY (1)	MY140325A (sr)
NO (1)	NO20061334L (sr)
NZ (1)	NZ546186A (sr)
PL (1)	PL1707564T3 (sr)
PT (1)	PT1707564E (sr)
RS (1)	RS50527B (sr)
SG (1)	SG126113A1 (sr)
SI (1)	SI1707564T1 (sr)
TN (1)	TNSN07357A1 (sr)
UA (1)	UA87989C2 (sr)
WO (1)	WO2006103342A2 (sr)
ZA (1)	ZA200602631B (sr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8071778B2 (en) *	2006-07-27	2011-12-06	Bristol-Myers Squibb Company	Substituted heterocyclic ethers and their use in CNS disorders
US8026257B2 (en) *	2007-07-11	2011-09-27	Bristol-Myers Squibb Company	Substituted heterocyclic ethers and their use in CNS disorders
US20090018163A1 (en) *	2007-07-11	2009-01-15	Bristol-Myers Squibb Company	Substituted Heterocyclic Ethers and Their Use in CNS Disorders
US7632861B2 (en) *	2007-11-13	2009-12-15	Bristol-Myers Squibb Company	Substituted heterocyclic ethers and their use in CNS disorders
EP3628672A1 (en)	2018-09-25	2020-04-01	Antabio SAS	Indane derivatives for use in the treatment of bacterial infection
WO2020064175A1 (en)	2018-09-25	2020-04-02	Antabio Sas	Indane derivatives for use in the treatment of bacterial infection
EP3628666A1 (en)	2018-09-25	2020-04-01	Antabio SAS	Indane derivatives for use in the treatment of bacterial infection
MA53707A (fr)	2018-09-25	2021-12-29	Antabio Sas	Dérivés d'indane destinés à être utilisés dans le traitement d'une infection bactérienne
US20240016941A1 (en)	2020-03-24	2024-01-18	Antabio Sas	Combination therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1335591C (en) *	1988-05-23	1995-05-16	James Arthur Nixon	Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes
DK286990D0 (da) *	1990-12-04	1990-12-04	Lundbeck & Co As H	Indanderivater
CA2175395A1 (en) *	1995-06-02	1996-12-03	Ronald J. Mattson	Melatonergic indanyl piperazines or homopiperazines
FR2769312B1 (fr) *	1997-10-03	1999-12-03	Adir	Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2827284B1 (fr) *	2001-07-16	2003-10-31	Servier Lab	Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2004042351A2 (en) *	2002-10-30	2004-05-21	Merck & Co., Inc.	Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity

2005
- 2005-03-30 FR FR0503071A patent/FR2883876B1/fr not_active Expired - Fee Related
2006
- 2006-03-16 MA MA28880A patent/MA28211A1/fr unknown
- 2006-03-23 NO NO20061334A patent/NO20061334L/no not_active Application Discontinuation
- 2006-03-28 NZ NZ546186A patent/NZ546186A/en not_active IP Right Cessation
- 2006-03-28 SG SG200602026A patent/SG126113A1/en unknown
- 2006-03-28 GE GEAP20069324A patent/GEP20084544B/en unknown
- 2006-03-29 PT PT06290494T patent/PT1707564E/pt unknown
- 2006-03-29 MY MYPI20061369A patent/MY140325A/en unknown
- 2006-03-29 SI SI200630005T patent/SI1707564T1/sl unknown
- 2006-03-29 WO PCT/FR2006/000673 patent/WO2006103342A2/fr not_active Application Discontinuation
- 2006-03-29 UA UAA200603429A patent/UA87989C2/ru unknown
- 2006-03-29 RS RSP-2007/0478A patent/RS50527B/sr unknown
- 2006-03-29 ES ES06290494T patent/ES2293630T3/es active Active
- 2006-03-29 DK DK06290494T patent/DK1707564T3/da active
- 2006-03-29 PL PL06290494T patent/PL1707564T3/pl unknown
- 2006-03-29 AP AP2007004169A patent/AP2007004169A0/xx unknown
- 2006-03-29 EP EP06290494A patent/EP1707564B1/fr active Active
- 2006-03-29 DE DE602006000102T patent/DE602006000102T2/de active Active
- 2006-03-29 EA EA200600487A patent/EA010051B1/ru not_active IP Right Cessation
- 2006-03-29 AT AT06290494T patent/ATE372992T1/de active
- 2006-03-29 US US11/391,916 patent/US7442692B2/en not_active Expired - Fee Related
- 2006-03-30 AR ARP060101238A patent/AR054747A1/es not_active Application Discontinuation
- 2006-03-30 CA CA2541066A patent/CA2541066C/fr not_active Expired - Fee Related
- 2006-03-30 CN CNB2006100669637A patent/CN100467458C/zh not_active Expired - Fee Related
- 2006-03-30 AU AU2006201326A patent/AU2006201326A1/en not_active Abandoned
- 2006-03-30 ZA ZA200602631A patent/ZA200602631B/xx unknown
- 2006-03-30 JP JP2006093025A patent/JP4503549B2/ja not_active Expired - Fee Related
- 2006-03-30 KR KR1020060029085A patent/KR100766664B1/ko not_active IP Right Cessation
- 2006-03-30 BR BRPI0602132-8A patent/BRPI0602132A/pt not_active IP Right Cessation
- 2006-03-30 MX MXPA06003552A patent/MXPA06003552A/es active IP Right Grant
2007
- 2007-02-01 HK HK07101184.7A patent/HK1096386A1/xx not_active IP Right Cessation
- 2007-09-18 TN TNP2007000357A patent/TNSN07357A1/en unknown
- 2007-09-19 IL IL186062A patent/IL186062A/en not_active IP Right Cessation
- 2007-09-24 CR CR9391A patent/CR9391A/es not_active Application Discontinuation
- 2007-09-28 GT GT200700084A patent/GT200700084A/es unknown
- 2007-10-25 HR HR20070498T patent/HRP20070498T3/xx unknown
- 2007-11-28 CY CY20071101540T patent/CY1107028T1/el unknown

Also Published As

Publication number	Publication date
CY1107028T1 (el)	2012-09-26
MA28211A1 (fr)	2006-10-02
EP1707564A3 (fr)	2006-11-15
EA010051B1 (ru)	2008-06-30
IL186062A (en)	2010-12-30
ZA200602631B (en)	2007-06-27
SG126113A1 (en)	2006-10-30
US20060223830A1 (en)	2006-10-05
DE602006000102T2 (de)	2008-06-26
DE602006000102D1 (de)	2007-10-25
CN100467458C (zh)	2009-03-11
WO2006103342A3 (fr)	2006-12-07
US7442692B2 (en)	2008-10-28
FR2883876B1 (fr)	2007-05-04
EA200600487A1 (ru)	2006-10-27
JP4503549B2 (ja)	2010-07-14
CR9391A (es)	2008-01-21
NO20061334L (no)	2006-10-02
ES2293630T3 (es)	2008-03-16
KR100766664B1 (ko)	2007-10-12
ATE372992T1 (de)	2007-09-15
WO2006103342A2 (fr)	2006-10-05
HK1096386A1 (en)	2007-06-01
CA2541066C (fr)	2010-08-24
NZ546186A (en)	2007-04-27
CN1840527A (zh)	2006-10-04
MXPA06003552A (es)	2006-09-29
WO2006103342A8 (fr)	2007-12-21
PT1707564E (pt)	2007-10-16
GT200700084A (es)	2009-05-22
EP1707564A2 (fr)	2006-10-04
GEP20084544B (en)	2008-11-25
SI1707564T1 (sl)	2007-12-31
AP2007004169A0 (en)	2007-10-31
AR054747A1 (es)	2007-07-11
IL186062A0 (en)	2008-01-20
JP2006282669A (ja)	2006-10-19
EP1707564B1 (fr)	2007-09-12
MY140325A (en)	2009-12-31
KR20060105606A (ko)	2006-10-11
FR2883876A1 (fr)	2006-10-06
DK1707564T3 (da)	2008-01-21
BRPI0602132A (pt)	2007-08-14
CA2541066A1 (fr)	2006-09-30
AU2006201326A1 (en)	2006-10-19
UA87989C2 (ru)	2009-09-10
PL1707564T3 (pl)	2008-01-31
WO2006103342A9 (fr)	2007-10-25
HRP20070498T3 (en)	2007-12-31
TNSN07357A1 (en)	2008-12-31

Publication	Publication Date	Title
RS50527B (sr)	2010-05-07	Derivati indanil-piperazina, proces njihove izrade i farmaceutske smeše koje ih sadrže
RS53059B (sr)	2014-04-30	Novi supstituisani imidazohinolini
AR066171A1 (es)	2009-07-29	Derivados de nicotinamida, composiciones farmaceuticas que los contienen, metodo de preparacion de los mismos y usos en la prevencion y/o tratamiento del cancer.
RS52562B (sr)	2013-04-30	(3-aril-piperazin-1-il) derivati 6,7-dialkoksikvinazolina, 6,7- dialkoksiftalazina i 6,7-dialkoksiizokvinolina
CO4920234A1 (es)	2000-05-29	Derivados de acidos arilsulfonilaminomidroxamicos
EA201490554A1 (ru)	2015-06-30	Пирролобензодиазепины
ATE517663T1 (de)	2011-08-15	Photostabile organische sonnenschutzverbindungen mit antioxidationseigenschaften und daraus gewonnene zusammensetzungen
WO2008107502A8 (es)	2009-07-23	Composicion para el tratamiento de enfermedades infecciosas
RS51133B (sr)	2010-10-31	Novi triciklični derivati, postupak za njihovu proizvodnju i farmaceutske smeše koje ih sadrže
EA201070010A1 (ru)	2010-06-30	Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии
HRP20080097T5 (en)	2008-10-31	Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists
IT1320162B1 (it)	2003-11-18	Derivati della tirosina ad attivita' anti leucotrienica, procedimentoper la loro preparazione e loro uso farmaceutico.
EA201071014A1 (ru)	2011-04-29	Новые 7-замещенные производные 3-карбоксиоксадиазинохинолонов, способ их получения и применение в качестве антибактериальных средств
EA200001101A1 (ru)	2001-06-25	НОВЫЕ ДИГИДРОФУРО[3,4-b]ХИНОЛИН-1-ОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
DE50304891D1 (de)	2006-10-12	N-aryl-4,5-diaminopyrazole und diese verbindungen enthaltende färbemittel
RS52046B (sr)	2012-04-30	Kombinacija bis-tiazolijum soli ili njenog prekursora i artemisinina ili njegovog derivata za lečenje akutne malarije
GB0617867D0 (en)	2006-10-18	Chemical compounds
EA200301171A1 (ru)	2004-04-29	Новые соединения трициклических дигидрохинолинов, способ их получения и фармацевтические композиции, содержащие их
CY1112596T1 (el)	2016-02-10	Νεες ενωσεις και χρηση αυτων
SE1069132T3 (sv)	2003-12-09	Bicykliska derivate av amino-pyrazinoner, foerfarande foer framstaellning och farmaceutiska kompositioner innehallande dem
RS50547B (sr)	2010-05-07	Derivati 4-okso-4,6,7,8-tetrahidropirolo-1,2-a pirazin-6-karboksamida, postupak njihove izrade i farmaceutske smeše koje ih sadrže
FR2903698B1 (fr)	2009-01-30	Nouveaux derives de 5-thioxylopyranose.
HRP20090090T3 (en)	2009-03-31	Novel polysubstituted 1,1-pyridinylaminocyclopropanamine derivatives, processes for their preparation and pharmaceutical composition containing them
HRP20080536T5 (en)	2009-03-31	Polysubstituted 1,1-pyridinyloxycyclopropanamine derivatives, process for their preparation and pharmaceutical compositions containing them
AR036680A1 (es)	2004-09-29	Procedimiento para preparar derivados de heterocicloalquilsulfonilpirazol y compuestos utiles en su preparacion